149 related articles for article (PubMed ID: 11735105)
1. Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.
Kjalke M; Johannessen M; Hedner U
Semin Hematol; 2001 Oct; 38(4 Suppl 12):15-20. PubMed ID: 11735105
[TBL] [Abstract][Full Text] [Related]
2. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood.
Gerotziafas GT; Depasse F; Chakroun T; Samama MM; Elalamy I
Thromb Haemost; 2004 Mar; 91(3):531-7. PubMed ID: 14983229
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Lisman T; Adelmeijer J; Cauwenberghs S; Van Pampus EC; Heemskerk JW; De Groot PG
J Thromb Haemost; 2005 Apr; 3(4):742-51. PubMed ID: 15842358
[TBL] [Abstract][Full Text] [Related]
5. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
Wegert W; Harder S; Bassus S; Kirchmaier CM
Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
Aljamali MN; Kjalke M; Hedner U; Ezban M; Tranholm M
Haemophilia; 2009 Nov; 15(6):1318-26. PubMed ID: 19659796
[TBL] [Abstract][Full Text] [Related]
7. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.
Kjalke M; Ezban M; Monroe DM; Hoffman M; Roberts HR; Hedner U
Br J Haematol; 2001 Jul; 114(1):114-20. PubMed ID: 11472355
[TBL] [Abstract][Full Text] [Related]
8. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
9. How factor VIIa works in hemophilia.
Butenas S; Brummel KE; Bouchard BA; Mann KG
J Thromb Haemost; 2003 Jun; 1(6):1158-60. PubMed ID: 12871314
[TBL] [Abstract][Full Text] [Related]
10. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
[TBL] [Abstract][Full Text] [Related]
12. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
Larsen OH; Clausen N; Persson E; Ezban M; Ingerslev J; Sørensen B
Br J Haematol; 2009 Jan; 144(1):99-106. PubMed ID: 19016728
[TBL] [Abstract][Full Text] [Related]
13. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
Weeterings C; Lisman T; de Groot PG
Semin Hematol; 2008 Apr; 45(2 Suppl 1):S12-5. PubMed ID: 18544417
[TBL] [Abstract][Full Text] [Related]
15. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
Livnat T; Zivelin A; Martinowitz U; Salomon O; Seligsohn U
J Thromb Haemost; 2006 Jan; 4(1):192-200. PubMed ID: 16409469
[TBL] [Abstract][Full Text] [Related]
16. Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa.
Novak M; Hiden M; Rehak T; Rosenkranz A; Zebisch A; Sill H; Klaschka S; Muntean W
Hamostaseologie; 2008 Oct; 28 Suppl 1():S77-80. PubMed ID: 18958344
[TBL] [Abstract][Full Text] [Related]
17. The effect of active site-inhibited factor VIIa on tissue factor-initiated coagulation using platelets before and after aspirin administration.
Kjalke M; Oliver JA; Monroe DM; Hoffman M; Ezban M; Hedner U; Roberts HR
Thromb Haemost; 1997 Oct; 78(4):1202-8. PubMed ID: 9364985
[TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
Tranholm M; Rojkjaer R; Pyke C; Kristensen AT; Klitgaard B; Lollike K; Blajchman MA
Thromb Res; 2003 Feb; 109(4):217-23. PubMed ID: 12757777
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Carr ME; Martin EJ; Kuhn JG; Seremetis SV
Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo model.
Galán AM; Tonda R; Altisent C; Maragall S; Ordinas A; Escolar G
Semin Hematol; 2001 Oct; 38(4 Suppl 12):10-4. PubMed ID: 11735104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]